Search - tctmd.com

Displaying 41 - 60 of 80

Sort: Relevancy | Date

Presentation TCT 2017

Devices - Needles, Wires and Sheaths

Presenter: Paul Sorajja

October 31, 2017

Presentation TCT 2017

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presenter: Thomas F. Luscher, Fernando Alfonso

October 31, 2017

Presentation TCT 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presenter: Thomas F. Luscher, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Niels Peter Rønnow Sand

October 31, 2017

Presentation TCT 2017

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Thomas F. Luscher, Junbo Ge

October 31, 2017

Presentation TCT 2017

MARE: Ambulatory Electrocardiographic Monitoring With an Implantable Loop Recorder in Patients With New-Onset Persistent LBBB After TAVR

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Josep Rodés-Cabau

October 31, 2017

Presentation TCT 2017

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

Presenter: David P. Faxon, Joseph A. Hill, Wieneke Vlastra

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James

October 31, 2017

Presentation TCT 2017

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita

October 31, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

Presentation TCT 2017

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

Transseptal Wet Models

Presenter: Mayra Guerrero

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

Advertisement

Devices - Needles, Wires and Sheaths

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

MARE: Ambulatory Electrocardiographic Monitoring With an Implantable Loop Recorder in Patients With New-Onset Persistent LBBB After TAVR

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Transseptal Wet Models

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content